The Top 10 Biotech Companies Brewing at Oxford
Here are the top biotech companies in Oxford, a city with an old scientific tradition…
September 17, 2020 - 8 minutes
Adaptimmune
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
January 15, 2020 - 2 minutes
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there…
May 21, 2019 - 12 minutes
How To Break Into The Crowded Immuno-Oncology Space
The field of immuno-oncology promises to make anti-cancer treatments more effective than ever. But in…
September 11, 2018 - 6 minutes
Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy
Following successful pilot studies, Adaptimmune will increase the dose of its T-cell therapy 10-fold to…
January 9, 2018 - 3 minutes
GSK wants in on Adaptimmune’s Adaptable T cell Cancer Treatment
GSK has backed Adaptimmune in the development of their adaptable NY-ESO SPEAR T cell cancer…
September 8, 2017 - 2 minutes
Which EU Immuno-Oncology Company are you Cheering for?
Immuno-oncology represents a huge breakthrough towards the search for a cancer cure. Biotechs all around…
April 20, 2017 - 1 minute
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for…
February 13, 2017 - 2 minutes
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
December 23, 2016 - 5 minutes
Cell Therapies: Is Commercialization holding back a Breakthrough?
How far away is biotech from a breakthrough with cell and gene therapy? While these…
November 16, 2016 - 4 minutes
UPDATE: FDA Lifts Hold on Adaptimmune’s Rare Cancer Trials
The FDA puts one of Adaptimmune's TCR trials on a partial hold, pending more information…
November 10, 2016 - 3 minutes
TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some…
October 28, 2016 - 2 minutes
